The increasing trend of vaping 5MeO dimethyltryptamine in Canada presents considerable dangers and challenging statutory problems. Currently, 5meo copyright remains a Schedule I substance according to Canadian Controlled Drugs and Substances Act, making its holding and distribution illegal. While inhalation delivers the chemical quickly, it further